Hsiu‐Chi Cheng - Concepedia

Author

Hsiu‐Chi Cheng

National Cheng Kung University Hospital ORCID

Also Known As

Cheng, Hsiu-Chi, H C Cheng, H Cheng, H. Cheng, H.-C. Cheng, H.‐C. CHENG, H.‐C. Cheng, HSIU‐CHI CHENG, Hsiu-Chi Cheng, Hsiu-Chi Cheng

113

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

National Cheng Kung University Hospital National Cheng Kung University Chest Hospital, Ministry of Health and Welfare National Taiwan University Hospital Cheng Hsin General Hospital

About

Hsiu‐Chi Cheng is an author at National Cheng Kung University Hospital specializing in medicine, gastroenterology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	419
2	Engineering	2	2	52
3	Data Science	2	2	52
4	Public Health	1	1	30
5	Biostatistics	1	1	30

Hsiu‐Chi Cheng

Publications

Citations

H-Index

Page 1

	Year	Citations
Screening and eradication of <i>Helicobacter pylori</i> for gastric cancer prevention: the Taipei global consensus Jyh‐Ming Liou, Peter Malfertheiner, Yi‐Chia Lee, Gut	2020	451
Pretreatment with Lactobacillus- and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy Bor‐Shyang Sheu, Hsiu‐Chi Cheng, Ai-Wen Kao, American Journal of Clinical Nutrition ProbioticAntimicrobial StewardshipFailed Triple TherapyQuadruple TherapyMicrobiology	2006	135
Consensus on the clinical management, screening‐to‐treat, and surveillance of <i>Helicobacter pylori</i> infection to improve gastric cancer control on a nationwide scale Bor‐Shyang Sheu, Ming‐Shiang Wu, Cheng‐Tang Chiu, Helicobacter	2017	79
Esomeprazole 40 mg twice daily in triple therapy and the efficacy of <i>Helicobacter pylori</i> eradication related to CYP2C19 metabolism B.‐S. Sheu, A.‐W. Kao, Hsiu‐Chi Cheng, Alimentary Pharmacology & Therapeutics	2005	74
Resistance to metronidazole, clarithromycin and levofloxacin of <i>Helicobacter pylori</i> before and after clarithromycin‐based therapy in Taiwan Wei‐Lun Chang, Bor‐Shyang Sheu, Hsiu‐Chi Cheng, Journal of Gastroenterology and Hepatology	2009	73
Elevated Serum Matrix Metalloproteinase-3 and -7 in H. pylori-Related Gastric Cancer Can Be Biomarkers Correlating with a Poor Survival Yi‐Chun Yeh, Bor‐Shyang Sheu, Hsiu‐Chi Cheng, Digestive Diseases and Sciences Prognostic BiomarkersSerum Matrix Metalloproteinase-3Gastrointestinal OncologyMedicineGastroenterology	2009	67
H. pylori Eradication Prevents the Progression of Gastric Intestinal Metaplasia in Reflux Esophagitis Patients Using Long-Term Esomeprazole Hsiao‐Bai Yang, Bor‐Shyang Sheu, Shin-Tar Wang, The American Journal of Gastroenterology	2009	47
The corpus‐predominant gastritis index may serve as an early marker of <i><scp>Helicobacter</scp> pylori‐</i>infected patients at risk of gastric cancer Y.‐C. Tsai, Wei-Hsin Hsiao, Hua Yang, Alimentary Pharmacology & Therapeutics	2013	46
Double oral esomeprazole after a 3-day intravenous esomeprazole infusion reduces recurrent peptic ulcer bleeding in high-risk patients: a randomised controlled study Hsiu‐Chi Cheng, Chung-Tai Wu, Wei-Lun Chang, Gut	2014	45
<i>H. pylori cagL</i> amino acid sequence polymorphism Y58E59 induces a corpus shift of gastric integrin α5β1 related with gastric carcinogenesis Yi‐Chun Yeh, Wei‐Lun Chang, Hsiao‐Bai Yang, Molecular Carcinogenesis GeneticsGenetic EpidemiologyGastroenterologyPathologyGastric Integrin	2011	45

Page 1